New HCV Therapies and Liver Transplantation.
作者信息
Werner Jens M, Vermehren Johannes
机构信息
1 Department of Surgery, University Hospital Regensburg, Regensburg, Bavaria, Germany. 2 Department of Internal Medicine, University Hospital Frankfurt, Frankfurt, Germany.
出版信息
Transplantation. 2016 Feb;100(2):260-1. doi: 10.1097/TP.0000000000001092.
PMID:26813409
Abstract
摘要
相似文献
1
New HCV Therapies and Liver Transplantation.
Transplantation. 2016 Feb;100(2):260-1. doi: 10.1097/TP.0000000000001092.
2
Management of recurrent hepatitis C virus after liver transplantation.
World J Gastroenterol. 2014 Nov 28;20(44):16409-17. doi: 10.3748/wjg.v20.i44.16409.
3
Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in.
Liver Transpl. 2015 Apr;21(4):423-34. doi: 10.1002/lt.24080.
4
Timing of Hepatitis C Antiviral Therapy in Liver Transplant Recipients With Direct-acting Agents.
Exp Clin Transplant. 2016 Jun;14(3):243-51.
5
Interferon-Free Therapy for Hepatitis C in Liver Transplant Recipients.
Transplantation. 2016 Jan;100(1):54-60. doi: 10.1097/TP.0000000000000860.
6
Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation.
Liver Transpl. 2016 Mar;22(3):287-97. doi: 10.1002/lt.24349.
7
Clinical decompensation after achieving SVR with sofosbuvir, daclatasvir and ribavirin in a patient with recurrent HCV post-liver transplant.
J Gastrointestin Liver Dis. 2015 Jun;24(2):257-8.
8
Epidemiology and outcome of hepatitis C relapse in transplant recipients.
Transplant Proc. 2011 Jul-Aug;43(6):2457-8. doi: 10.1016/j.transproceed.2011.06.016.
9
Optimum timing of treatment for hepatitis C infection relative to liver transplantation.
Lancet Gastroenterol Hepatol. 2016 Oct;1(2):165-172. doi: 10.1016/S2468-1253(16)30008-5. Epub 2016 Sep 8.
10
Hepatitis viruses and liver transplantation: evolving trends in antiviral management.
Clin Liver Dis. 2014 Aug;18(3):575-601. doi: 10.1016/j.cld.2014.05.002.
引用本文的文献
1
Predicting Early Viral Control under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers.
Front Immunol. 2018 Feb 7;9:146. doi: 10.3389/fimmu.2018.00146. eCollection 2018.
Zotero 插件